Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Carcinoma × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Uterine Cervical Neoplasms 8 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Solid Tumors 3 Urinary Bladder Neoplasms 2 Solid Tumor 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumors 1 Solid Tumor, Unspecified, Adult 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Biliary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡